#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14766	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2183	672.6	0	.	n	.	0	C1450T	SNP	1450	1450	C	1695	1695	T	807	T	738	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14766	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2183	672.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1429	1429	C	843	C	793	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27672	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3495	789.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1638	1638	A	932	A	863	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27672	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3495	789.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2272	2272	C	854	C	799	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27672	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3495	789.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2346	2346	A	906	A	847	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27672	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3495	789.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2898	2898	C	872	C,T	815,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	6	blaTEM	861	233	100.0	blaTEM.l6.c4.ctg.1	233	1.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2130	folP	855	855	100.0	folP.l15.c30.ctg.1	1583	133.9	1	SNP	p	R229S	1	.	.	685	687	AGC	986	988	AGC	190;193;190	A;G;C	181;183;178	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5824	gyrA	2751	2751	99.96	gyrA.l6.c30.ctg.1	3465	167.4	1	SNP	p	S91F	1	.	.	271	273	TTC	684	686	TTC	191;192;193	T;T;C	180;181;180	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5824	gyrA	2751	2751	99.96	gyrA.l6.c30.ctg.1	3465	167.4	1	SNP	p	D95G	1	.	.	283	285	GGC	696	698	GGC	199;194;193	G;G;C	186;180;179	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5824	gyrA	2751	2751	99.96	gyrA.l6.c30.ctg.1	3465	167.4	1	SNP	p	G95N	0	.	.	283	285	GGC	696	698	GGC	199;194;193	G;G;C	186;180;179	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1830	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1199	151.6	1	SNP	p	G45D	0	.	.	133	135	GGC	410	412	GGC	244;243;243	G;G;C	229;225;228	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	938	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	934	99.6	0	.	n	.	0	A197.	DEL	197	197	A	575	575	A	230	A	218	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5088	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2865	176.9	1	SNP	p	D86N	0	.	.	256	258	GAC	548	550	GAC	219;218;218	G;A;C	202;197;196	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5088	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2865	176.9	1	SNP	p	S87R	1	.	.	259	261	CGT	551	553	CGT	217;218;219	C;G;T	200;202;202	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5088	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2865	176.9	1	SNP	p	R87W	0	.	.	259	261	CGT	551	553	CGT	217;218;219	C;G;T	200;202;202	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5088	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2865	176.9	1	SNP	p	R87I	0	.	.	259	261	CGT	551	553	CGT	217;218;219	C;G;T	200;202;202	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5088	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2865	176.9	1	SNP	p	S88P	0	.	.	262	264	TCC	554	556	TCC	218;218;218	T;C;C	198;201;200	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4702	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2566	182.4	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1273	1275	TGC	196;196;198	T;G;C	177;172;177	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4702	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2566	182.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1483	1485	GGC	243;237;234	G;G;C	223;221;215	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	4094	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2545	160.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1266	1268	GCA	216;216;214	G,T;C;A	202,1;202;202	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4094	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2545	160.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1269	1271	ATC	215;214;216	A;T;C	200;200;203	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4094	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2545	160.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1281	1283	GTG	218;219;220	G;T;G,T	202;200;200,1	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4094	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2545	160.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1281	1283	GTG	218;219;220	G;T;G,T	202;200;200,1	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4094	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2545	160.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1785	1787	ACC	218;214;216	A;C;C,T	200;198;195,1	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4094	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2545	160.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1839	1841	GCG	205;205;207	G;C;G	178;165;177	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4094	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2545	160.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1839	1841	GCG	205;205;207	G;C;G	178;165;177	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4094	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2545	160.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1962	1964	GGC	159;160;159	G;G,T;C	147;147,1;147	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4094	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2545	160.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1971	1973	GGC	152;152;150	G;G;C	140;139;137	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4094	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2545	160.5	1	SNP	p	P552S	1	.	.	1654	1656	TCG	1989	1991	TCG	163;165;163	T,G;C,G;G	110,9;126,2;136	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6064	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3037	198.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1626	1628	CCG	207;207;204	C,T;C;G	180,1;189;182	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2476	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1808	136.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	598	598	C	184	C	167	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2784	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1400	196.4	0	.	p	.	0	N38E	NONSYN	112	114	AAT	337	339	GAA	269;270;267	G;A;A	256;255;253	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2784	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1400	196.4	0	.	p	.	0	N134D	NONSYN	400	402	AAT	625	627	GAT	232;232;232	G;A;T	216;217;220	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2784	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1400	196.4	0	.	p	.	0	P175S	NONSYN	523	525	CCA	748	750	TCA	246;246;246	T;C;A	226;226;227	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2784	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1400	196.4	0	.	p	.	0	D212N	NONSYN	634	636	GAT	859	861	AAT	211;213;218	A;A;T	197;199;201	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2784	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1400	196.4	0	.	p	.	0	F222L	NONSYN	664	666	TTT	889	891	CTT	239;234;237	C;T;T	219;216;218	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2784	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1400	196.4	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1207	1209	GCA	170;167;167	G;C;A	159;157;157	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2784	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1400	196.4	0	.	p	.	0	D333V	NONSYN	997	999	GAC	1222	1224	GTC	163;164;164	G,T;T;C	151,1;152;153	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2784	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1400	196.4	1	SNP	p	G120K	1	.	.	358	360	AAG	583	585	AAG	219;219;219	A;A;G	202;199;201	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2784	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1400	196.4	1	SNP	p	A121D	1	.	.	361	363	GAC	586	588	GAC	219;216;218	G,A;A,G;C	199,1;193,1;201	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2784	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1400	196.4	1	SNP	p	D121N	0	.	.	361	363	GAC	586	588	GAC	219;216;218	G,A;A,G;C	199,1;193,1;201	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10740	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4988	215.0	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2069	2071	AAT	209;211;211	A;A;T	196;196;197	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1114	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1223	91.0	1	SNP	p	V57M	1	.	.	169	171	ATG	632	634	ATG	233;233;235	A;T;G	214;216;217	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
